• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

作者信息

Hirsh J, Warkentin T E, Raschke R, Granger C, Ohman E M, Dalen J E

机构信息

Hamilton Civic Hospitals, Research Centre, ON, Canada.

出版信息

Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s.

DOI:10.1378/chest.114.5_supplement.489s
PMID:9822059
Abstract
摘要

相似文献

1
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.肝素与低分子量肝素：作用机制、药代动力学、给药考量、监测、疗效及安全性
Chest. 1998 Nov;114(5 Suppl):489S-510S. doi: 10.1378/chest.114.5_supplement.489s.
2
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.肝素与低分子量肝素：作用机制、药代动力学、给药剂量、监测、疗效及安全性
Chest. 2001 Jan;119(1 Suppl):64S-94S. doi: 10.1378/chest.119.1_suppl.64s.
3
LMWHs have additional advantage over unfractionated heparin: no volume load.低分子肝素与普通肝素相比还有额外的优势：无容量负荷。
Swiss Med Wkly. 2009 Oct 31;139(43-44):642. doi: 10.4414/smw.2009.12937.
4
'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).“肝素反跳”在心脏外科手术（出血）和心脏病学（血栓形成）中含义相反。
Blood Coagul Fibrinolysis. 2010 Mar;21(2):198-9. doi: 10.1097/MBC.0b013e3283370126.
5
[Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].[低分子量肝素用于深静脉血栓形成。所有体重级别的剂量]
MMW Fortschr Med. 2003 Jun 12;145(24):56.
6
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.肝素：作用机制、药代动力学、剂量考量、监测、疗效及安全性。
Chest. 1995 Oct;108(4 Suppl):258S-275S. doi: 10.1378/chest.108.4_supplement.258s.
7
European practice guidelines: thromboembolism prophylaxis and regional anesthesia.欧洲实践指南：血栓栓塞预防与区域麻醉
Reg Anesth Pain Med. 1998 Nov-Dec;23(6 Suppl 2):178-82. doi: 10.1016/s1098-7339(98)90144-4.
8
Letters on management of ischemic stroke.关于缺血性中风管理的信件
Am Fam Physician. 2012 Sep 15;86(6):492.
9
[Perioperative heparin bridging is rarely indicated].围手术期肝素桥接很少有必要。
Ugeskr Laeger. 2016 Feb 29;178(9):V12150952.
10
[Heparins].[肝素]
Ther Umsch. 2003 Jan;60(1):10-3. doi: 10.1024/0040-5930.60.1.10.

引用本文的文献

1
Molecular Insights into the Interaction between CD147 and the SARS-CoV‑2 Spike Protein.CD147与严重急性呼吸综合征冠状病毒2刺突蛋白相互作用的分子见解
ACS Omega. 2025 Aug 5;10(32):36025-36040. doi: 10.1021/acsomega.5c03562. eCollection 2025 Aug 19.
2
Multifunctional applications and research advances of low-molecular-weight heparin.低分子量肝素的多功能应用及研究进展
Front Pharmacol. 2025 May 21;16:1585762. doi: 10.3389/fphar.2025.1585762. eCollection 2025.
3
Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications.
他汀类药物作为血栓性抗磷脂综合征的辅助抗栓药物：作用机制及临床意义
Cells. 2025 Feb 28;14(5):353. doi: 10.3390/cells14050353.
4
Effect of endothelium on the anticoagulant activity of a covalent antithrombin-heparin complex.内皮细胞对共价型抗凝血酶-肝素复合物抗凝活性的影响。
Sci Rep. 2024 Sep 27;14(1):22335. doi: 10.1038/s41598-024-72458-0.
5
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时抗栓治疗的现状与未来方向
Rev Cardiovasc Med. 2022 Sep 5;23(9):297. doi: 10.31083/j.rcm2309297. eCollection 2022 Sep.
6
Early Mobilization after Cardiac Catheterization via Femoral Artery: A Systematic Review and Meta-Analysis.经股动脉心脏导管插入术后的早期活动：一项系统评价和荟萃分析。
Rev Cardiovasc Med. 2024 Apr 30;25(5):152. doi: 10.31083/j.rcm2505152. eCollection 2024 May.
7
Establishment of a swine model of delayed bleeding after endoscopic procedure.建立内镜手术后延迟出血的猪模型。
DEN Open. 2024 Jul 23;5(1):e411. doi: 10.1002/deo2.411. eCollection 2025 Apr.
8
Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children's medical center.目前那屈肝素的治疗剂量对患有血栓栓塞性疾病的新生儿和8个月以下婴儿是否足够？一项来自国家儿童医学中心的群体药代动力学研究。
Front Pharmacol. 2024 Jan 31;15:1331673. doi: 10.3389/fphar.2024.1331673. eCollection 2024.
9
Chemoprophylaxis and Management of Venous Thromboembolism in Microvascular Surgery.微血管手术中静脉血栓栓塞的化学预防与管理
Semin Plast Surg. 2023 Feb 9;37(1):57-72. doi: 10.1055/s-0042-1760381. eCollection 2023 Feb.
10
Not Just Anticoagulation-New and Old Applications of Heparin.肝素的新老应用：不止抗凝。
Molecules. 2022 Oct 17;27(20):6968. doi: 10.3390/molecules27206968.